A Clover Health Director Sold Over 67,000 Company Shares. Here's a Closer Look at the Transaction.

Impact · against what's priced in

Clover Health shows strong fundamental momentum through a swing to profitability and massive revenue growth, further bolstered by a favorable court ruling on Medicare ratings. While there was minor insider selling, the scale is small relative to total holdings and does not offset the positive shift in earnings and regulatory standing.

CLOV+0.70

No priced-in read yet